Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient

Journal of Korean Medical Science

Volumn 23, Issue 4, 2008, Pages 734-736

  Shim, GeumSook ^a   Kang, Do Hyung ^a   Jun, Soo Kwon ^a  

^a Seoul National University   (South Korea)

Author keywords

Chlorpromazine; Neuroleptic malignant syndrome; Rifampin

Indexed keywords

CHLORPROMAZINE; CREATINE KINASE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BLOOD; CASE REPORT; DRUG EFFECT; DRUG INTERACTION; ENZYME INDUCTION; HUMAN; MALE; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA;

ADULT; ANTITUBERCULAR AGENTS; CHLORPROMAZINE; CREATINE KINASE; DRUG INTERACTIONS; ENZYME INDUCTION; HUMANS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; RIFAMPIN; SCHIZOPHRENIA;

EID: 50449090683     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2008.23.4.734     Document Type: Article

References (12)

1. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 1137-45.
2. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77: 185-202.
3. Hynes AF, Vickar EL. Case study: neuroleptic malignant syndrome without pyrexia. J Am Acad Child Adolesc Psychiatry 1996; 35: 959-62.
4. Rodriguez OP, Dowell MS. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole. J Okla State Med Assoc 2006; 99: 435-8.
5. Totten VY, Hirschenstein E, Hew P. Neuroleptic malignant syndrome presenting without initial fever: a case report. J Emerg Med 1994; 12: 43-7.
6. Woodbury MM, Woodbury MA. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. J Am Acad Child Adolesc Psychiatry 1992; 31: 1161-4.
7. Gorski JC, Vannaprasaht S, Hamman MA, Ambrosius WT, Bruce MA, Haehner-Daniels B, Hall SD. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. Clin Pharmacol Ther 2003; 74: 275-87.
8. Kim YH, Cha IJ, Shim JC, Shin JG, Yoon YR, Kim YK, Kim JI, Park GH, Jang IJ, Woo JI, Shin SG. Effect of rifampin on the plasma concentration and the clinical effect of haloperidol concomitantly administered to schizophrenic patients. J Clin Psychopharmacol 1996; 16: 247-52.
9. Margetic B, Aukst-Margetic B. Neuroleptic malignant syndrome and clozapine withdrawal at the same time? Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 145-7.
10. Spivak B, Gonen N, Mester R, Averbuch E, Adlersberg S, Weizman A. Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents. Int Clin Psychopharmacol 1996; 11: 207-9.
11. Choi RL, Roth RH. Development of supersensitivities of apomorphine induced increases in acetylcholine levels and stereotype after chronic fluphenazine treatment. Neuropharmacology 1978; 17: 59-64.
12. Amore M, Zazzeri N. Neuroleptic malignant syndrome after neuroleptic discontinuation. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 1323-34.